Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.
暂无分享,去创建一个
Dean A Fergusson | J. Marshall | D. Fergusson | R. Zarychanski | L. McIntyre | A. Abou-Setta | John C Marshall | Lauralyn McIntyre | Alexis F Turgeon | Ahmed M Abou-Setta | Ryan Zarychanski | A. Turgeon | Brett L Houston | B. Houston | Brett L. Houston | J. Marshall
[1] G. Hempelmann,et al. The Effects of Albumin Versus Hydroxyethyl Starch Solution on Cardiorespiratory and Circulatory Variables in Critically III Patients , 1996, Anesthesia and analgesia.
[2] D. Birolini,et al. Use of Pentastarch Solution in the Treatment of Patients with Hemorrhagic Hypovolemia: Randomized Phase II Study in the Emergency Room , 1998, World Journal of Surgery.
[3] K. Nagy,et al. A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock. , 1993, Circulatory shock.
[4] J. Tenhunen,et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. , 2012, The New England journal of medicine.
[5] C. Natanson,et al. Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses , 2012, Intensive Care Medicine.
[6] J. Higgins,et al. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .
[7] P. Gosling,et al. Hydroxyethylstarch supplementation in burn resuscitation--a prospective randomised controlled trial. , 2010, Burns : journal of the International Society for Burn Injuries.
[8] G. Hempelmann,et al. Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. , 1996, Critical care medicine.
[9] T. Neff,et al. Pharmacokinetics of Hydroxyethyl Starch , 2005, Clinical pharmacokinetics.
[10] P. Coriat,et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients , 1996, The Lancet.
[11] Q. Xia,et al. Hydroxyethyl Starch Resuscitation Reduces the Risk of Intra-Abdominal Hypertension in Severe Acute Pancreatitis , 2011, Pancreas.
[12] G. Hempelmann,et al. Influence of different volume therapy regimens on regulators of the circulation in the critically ill. , 1996, British journal of anaesthesia.
[13] J. Bromilow,et al. Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis , 2013 .
[14] Chunmao Han,et al. [Evaluation of effectiveness and safety of a new hydroxyethyl starch used in resuscitation of burn shock]. , 2006, Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns.
[15] W. Padberg,et al. Does the type of volume therapy influence endothelial-related coagulation in the critically ill? , 1995, British journal of anaesthesia.
[16] J. Verheij,et al. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia* , 2009, Critical care medicine.
[17] P Rama-Maceiras,et al. [Fraudulent pain research: a hurt so deep nothing can alleviate it]. , 2009, Revista espanola de anestesiologia y reanimacion.
[18] J. Bérard,et al. Hydroxyéthylamidons Versus Gélatines: Impact Sur Le Coût Du Remplissage Dans Un Service De Réanimation , 1995 .
[19] R. Bellomo,et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. , 2012, The New England journal of medicine.
[20] L. Brochard,et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study , 2001, The Lancet.
[21] G. Hempelmann,et al. Volume therapy in the critically ill: is there a difference? , 1998, Intensive Care Medicine.
[22] Rolf Rossaint,et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.
[23] B. Erstad,et al. A Paradigm for Consensus: The University Hospital Consortium Guidelines for the Use of Albumin, Nonprotein Colloid, and Crystalloid Solutions , 1995 .
[24] S. Finfer,et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. , 2012, Anesthesia and analgesia.
[25] T. Szakmany,et al. Fluid resuscitation with colloids of different molecular weight in septic shock , 2004 .
[26] W. Padberg,et al. The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients , 1996, Anaesthesia.
[27] M. Weil,et al. Effects of Hetastarch and Albumin on Coagulation in Patients with Septic Shock , 1988, Journal of clinical pharmacology.
[28] C. Mecher,et al. Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. , 1989 .
[29] P. Asfar,et al. Assessment of hemodynamic and gastric mucosal acidosis with modified fluid gelatin versus 6% hydroxyethyl starch: a prospective, randomized study , 2000, Intensive Care Medicine.
[30] Hui-ying Zhao,et al. [The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock]. , 2012, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue.
[31] B. Erstad,et al. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. , 1995, Archives of internal medicine.
[32] D. Cook,et al. Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials , 2009, Open medicine : a peer-reviewed, independent, open-access journal.
[33] A. Wakefield,et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. , 1998, Lancet.
[34] M. Flaig,et al. Hydroxyethyl starch‐induced itch: Relevance of light microscopic analysis of semi‐thin sections and electron microscopy , 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[35] Gilles Clermont,et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis , 2006, Critical care.
[36] P. Navsaria,et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). , 2011, British journal of anaesthesia.
[37] Attila Havas,et al. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients , 2010, European journal of anaesthesiology.
[38] P. Svoboda,et al. Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. , 2009, Hepato-gastroenterology.
[39] C. Ince,et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. , 2010, Journal of critical care.
[40] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[41] Feng Li,et al. [The effect of different fluids on early fluid resuscitation in septic shock]. , 2008, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue.
[42] G. Hempelmann,et al. Influence of different volume therapies on platelet function in the critically ill , 1996, Intensive Care Medicine.
[43] D. Cook,et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial , 2008, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[44] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[45] T. Lancet,et al. Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 2010, The Lancet.
[46] J. Edwards,et al. Comparison of the hemodynamic and oxygen transport responses to modified fluid gelatin and hetastarch in critically ill Patients: A prospective, randomized trial , 1994, Critical care medicine.
[47] W. Jurecka,et al. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. , 1999, British journal of anaesthesia.
[48] J. Carlisle,et al. The analysis of 168 randomised controlled trials to test data integrity , 2012, Anaesthesia.
[49] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[50] Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions , 1982, Critical care medicine.
[51] Yong-sheng Shao,et al. [The study of hypertonic saline and hydroxyethyl starch treating severe sepsis]. , 2011, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue.
[52] Jonathan J Deeks,et al. Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events , 2007, Statistics in medicine.
[53] P. Perel,et al. Colloids versus crystalloids for fluid resuscitation in critically ill patients. , 2013, The Cochrane database of systematic reviews.
[54] J. Heltne,et al. Capillary leakage in post-cardiac arrest survivors during therapeutic hypothermia - a prospective, randomised study , 2010, Scandinavian journal of trauma, resuscitation and emergency medicine.
[55] T. Veneman,et al. Human albumin and starch administration in critically ill patients: A prospective randomized clinical trial , 2004, Wiener Klinische Wochenschrift.
[56] M. Inal,et al. Effects of polygeline and hydroxyethyl starch solutions on liver functions assessed with LIMON in hypovolemic patients. , 2010, Journal of critical care.
[57] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[58] T. Randell,et al. Peroperative fluid management of the brain‐dead multiorgan donor , 1990, Acta anaesthesiologica Scandinavica.
[59] Tsuguya Fukui,et al. Systematic Evaluation and Comparison of Statistical Tests for Publication Bias , 2005, Journal of epidemiology.
[60] P. Rama-Maceiras,et al. Algología fraudulenta. Un dolor demasiado profundo para una adecuada analgesia , 2009 .
[61] B. Guidet,et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study , 2012, Critical Care.
[62] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[63] Abstracts of the 9th Congress of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA). April 12-16, 2011. Cape Town, South Africa. , 2011, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[64] P. Alderson,et al. Colloid solutions for fluid resuscitation. , 2003, The Cochrane database of systematic reviews.
[65] G. Orliaguet,et al. Remplissage vasculaire préhospitalier en traumatologie: Hesteril® 6 % versus Plasmion® , 2000 .